Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19
Clinical trial NCT04527471 · COMPLETED
Trial details
- NCT number
- NCT04527471
- Sponsor
- Verona Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2021-02-15
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.